What is Harmonic Bionics?
Harmonic Bionics operates at the intersection of advanced robotics and physical medicine. By developing intelligent, data-centric hardware, the company empowers clinicians to provide more precise, objective treatment for patients suffering from movement-related disabilities. Their market position is defined by a commitment to evidence-based rehabilitation, moving away from subjective assessment toward quantifiable, robotic-assisted therapy. Headquartered in Austin, Texas, the firm leverages a robust network of international investors to bridge the gap between cutting-edge engineering and practical clinical application.
How much funding has Harmonic Bionics raised?
Harmonic Bionics has raised a total of $10.2M across 3 funding rounds:
Debt
$174K
Series A
$7M
Other Financing Round
$3M
Debt (2021): $174K with participation from PPP
Series A (2021): $7M led by Smilegate Investment, KNet Investment Partners, Bass Investment, DSC Investment, and Big Basin Capital
Other Financing Round (2022): $3M supported by CUREXO
Key Investors in Harmonic Bionics
KNet Investment Partners
A venture capital firm founded in 2008 that focuses on high-growth sectors, leveraging a team of experienced professionals from top-tier financial and industrial institutions.
Big Basin Capital
An investment firm specializing in early-stage startups across Korea and the United States, with a specific focus on nurturing innovative medical technologies and SaaS platforms.
CUREXO
A South Korean medical device manufacturer established in 1992, specializing in the development and distribution of advanced robotic systems for surgical and rehabilitation applications.
What's next for Harmonic Bionics?
With the recent infusion of $3M, Harmonic Bionics is well-positioned to transition from its current growth phase into a broader enterprise-level deployment. The strategic focus will likely shift toward the commercialization of its robotic systems and the expansion of its clinical footprint. By leveraging the expertise of its diverse investor base, the company is expected to prioritize R&D initiatives that enhance the efficacy of its neurological treatment protocols, ultimately aiming to set a new standard for musculoskeletal care in both domestic and international markets.
See full Harmonic Bionics company page
